SCHEMBL278902

SCHEMBL278902

CPP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14958911 0.72
Ethylene SCHEMBL11414916 0.67
SCHEMBL800202 0.61
SCHEMBL49945 0.61
Phosphine SCHEMBL9007695 0.55
SCHEMBL18919813 0.55
Hydrochloric Acid SCHEMBL641352 0.55
SCHEMBL18920332 0.55
SCHEMBL9227174 0.55
Ethane SCHEMBL6550234 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118788390-A Cobalt-rhodium bimetallic catalyst coordinated by bidentate phosphorus ligand, and preparation method and application thereof 中国石油化工股份有限公司 2024-10-18 CN disclosed
US-12043683-B2 Dental materials based on redox systems with oligomeric cumene hydroperoxide derivatives IVOCLAR VIVADENT AG (LI) 2024-07-23 US disclosed
EP-4091707-B1 APPARATUS FOR THE PRODUCTION OF MELAMINE PROMAN AG (CH) 2024-07-03 EP disclosed
US-20240209520-A1 APPARATUS FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND AND METHOD FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2024-06-27 US disclosed
US-20240209009-A1 PEPTIDES COMPRISING A PHOSPHORYLCHOLINE CONJUGATE AND METHODS OF SYNTHESIZING SAME TARSIER PHARMA LTD. (IL) 2024-06-27 US disclosed
WO-2024126665-A1 LIGHTWEIGHT TIRE COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-06-20 WO disclosed
WO-2024126658-A1 LIGHTWEIGHT PNEUMATIC TIRE COMPRISING A PLY OF CIRCUMFERENTIAL REINFORCING ELEMENTS COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-06-20 WO disclosed
WO-2024126662-A1 TYRE HAVING IMPROVED ENDURANCE PERFORMANCE COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-06-20 WO disclosed
EP-4332270-A1 APPARATUS FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND AND METHOD FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND Idemitsu Kosan Co., Ltd (JP) 2024-03-06 EP disclosed
CN-114933613-B Preparation of PNNP ligand, ethylene oligomerization catalyst and application thereof 万华化学集团股份有限公司 2024-02-27 CN disclosed
EP-1311213-A1 VAGINAL DELIVERY OF BISPHOSPHONATES UMD, Inc. (US) 2003-05-21 EP disclosed
CN-1405098-A Biological-film method for treating city sewage UNIV GUANGZHOU (CN) 2003-03-26 CN disclosed
EP-1131100-B1 THERAPEUTIC COMPOSITIONS FOR METABOLIC BONE DISORDERS OR BONE METASTASES COMPRISING A PHOTOSENSITIZER AND A BISPHOSPHONATE LIGHT SCIENCES CORP (US) 2003-03-12 EP disclosed
US-20030018371-A1 Compositions and methods for the treatment of metabolic bone disorders and bone metastases LIGHT SCIENCES CORPORATION 2003-01-23 US disclosed
US-20020142997-A1 Liquid pharmaceutical composition for treating bone diseases RIDERWAY CORPORATION 2002-10-03 US disclosed
WO-2002070438-A2 COMPOSITIONS FOR DELIVERING BISPHOSPHONATES EMISPHERE TECHNOLOGIES, INC. (US) 2002-09-12 WO disclosed
EP-1228761-A2 Liquid pharmaceutical composition for treating bone diseases Riderway Corporation (PA) 2002-08-07 EP disclosed
WO-2002009631-A1 VAGINAL DELIVERY OF BISPHOSPHONATES UMD, INC. (US) 2002-02-07 WO disclosed
EP-1131100-A2 THERAPEUTIC COMPOSITIONS FOR METABOLIC BONE DISORDERS OR BONE METASTASES Light Sciences Corporation (US) 2001-09-12 EP disclosed
WO-2000041725-A2 THERAPEUTIC COMPOSITIONS FOR METABOLIC BONE DISORDERS OR BONE METASTASES LIGHT SCIENCES CORPORATION (US) 2000-07-20 WO disclosed